Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHONGQING PHARMA RES INST
- Publication Date
- 2006-08-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The present invention relates to a new medical application of an elastase (neutrophil elastase, NE) inhibitor, and more specifically relates to the application of the neutrophil elastase inhibitor sivelestat in the preparation of a drug for preventing or / and treating cerebral hemorrhage. Background technique
[0002] Intracerebral hemorrhage (ICH) refers to non-traumatic intraparenchymal hemorrhage. After cerebral hemorrhage, in addition to the space-occupying damage of the hematoma itself, there are blood circulation disorders in the surrounding brain tissue, a decrease in the flow rate of local cerebral hemorrhage, metabolic disorders, Inflammatory reactions, etc., which lead to damage of surrounding cells and brain edema, resulting in neurological deficits.
[0003] Stroke is a common clinical emergency, mostly in middle-aged and elderly patients. With the aging of the population, the incidence of this disease is also increasing. Hemorrhagic stroke ...